The gene therapy boom. The frustration of failure after failure in Alzheimer’s disease. The critical interplay between venture firms and “crossover” investors in a volatile, unpredictable macro-environment. The growing need for (and role of) diversity initiatives within the life sciences community—and the personal stories behind them.
These are just some of the topics Xconomy will be featuring this year at our annual half-day forum, “What’s Hot in Boston Biotech,” on May 21 at the Cambridge, MA, offices of Bristol-Myers Squibb (NYSE: BMY). We’ve amassed an eclectic group of speakers and topics in a… Read more »
UNDERWRITERS AND PARTNERS